Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel (Record no. 27769009)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02363 a2200601 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517183928.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201807s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1540-1413 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.6004/jnccn.2017.7018 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Rodríguez-Moreno, Juan Francisco |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180705 |
245 00 - TITLE STATEMENT | |
Title | Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of the National Comprehensive Cancer Network : JNCCN |
Date of publication, distribution, etc. | 11 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1310-1315 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomarkers, Tumor |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bone Neoplasms |
General subdivision | diagnostic imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Renal Cell |
General subdivision | diagnostic imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Denosumab |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gain of Function Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kidney Neoplasms |
General subdivision | diagnostic imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Liver Neoplasms |
General subdivision | diagnostic imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Magnetic Resonance Imaging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mechanistic Target of Rapamycin Complex 1 |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Metastasectomy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation, Missense |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Positron Emission Tomography Computed Tomography |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Kinase Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Response Evaluation Criteria in Solid Tumors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Signal Transduction |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sirolimus |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | TOR Serine-Threonine Kinases |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tumor Suppressor Proteins |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ubiquitin Thiolesterase |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Exome Sequencing |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Apellaniz-Ruiz, María |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Roldan-Romero, Juan María |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Durán, Ignacio |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Beltrán, Luis |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Montero-Conde, Cristina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cascón, Alberto |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Robledo, Mercedes |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | García-Donas, Jesus |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rodríguez-Antona, Cristina |
773 0# - HOST ITEM ENTRY | |
Title | Journal of the National Comprehensive Cancer Network : JNCCN |
Related parts | vol. 15 |
-- | no. 11 |
-- | p. 1310-1315 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.6004/jnccn.2017.7018">https://doi.org/10.6004/jnccn.2017.7018</a> |
Public note | Available from publisher's website |
No items available.